Home / Resources / Unlock Diversity in Clinical Trials: Top 10 Tips for Crafting a Successful Action Plan
Unlock Diversity in Clinical Trials: Top 10 Tips for Crafting a Successful Action Plan

The latest guidance urges sponsors and investigators to consider the many dimensions of clinical trial diversity. See the top 10 tips on how to craft a successful action plan.

''
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Thank you.




Your download should open in a new window. You can also manually download by clicking the button below.
Related products
Citeline subscriber exploring the diversity feasibility using Global Patient Insights.
Global Patient Insights
スポンサーによる治験責任医師の選定を最適化し、多様性目標の迅速な達成を支援します。
Site investigator exploring the matched patients to their trial.
Citeline PatientMatch
治験対象となり得る患者が施設に来院した際に、サイトスタッフやCROに通知することで、参加の可能性を最大限に引き出します。
Clinical trial participant discussing trial details
Citeline Connect
世界中の臨床試験の参加者を見つけて教育し、参加させ、登録するためのエンドツーエンドのソリューション

Related resources

Patients in a waiting room with healthcare professionals.
JUN 27, 2024
Article
Clinical

Deciphering the FDA Diversity Plan Updated Guidance

On June 26, the FDA released updated guidance on diversity action plans. See what the guidance means for clinical trial sponsors.

Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial
Use Case
Patient Engagement & Recruitment

Accelerating Diversity Enrollment in a Phase III COVID-19 Clinical Trial

A biotech need to rapidly meet diversity/inclusion goals for a high-profile Phase III COVID-19 trial. Citeline Connect helped the sponsor recover from a 72% decline in diversity-focused randomizations, delivering 20-25% of daily randomizations in 32 days.

A digital representation of the future of healthcare, showcasing the integration of technology and medicine.
JUN 01, 2023
Whitepaper
Clinical

The Need for Better Diversity Data in Clinical Trial Benchmarking and Feasibility

Just as marginalized patients face barriers to clinical trial participation, study sponsors face challenges in obtaining clinical trial diversity data.

View all